Economy & Marketsnational✓ verified · 90%
8-K material event: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- When
- Where
- US
- Category
- corporate_filing · form_8k
Filed: 2026-06-16 AccNo: 0001493152-26-028878 Size: 816 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Sources
- SEC EDGAR ↗ · first seen 2026-06-16 20:00 UTC
Defaxon links out to the original reporting and never republishes article text.
Correlated events
Computed by the Defaxon correlation engine — linked by shared actors, co-location, and temporal proximity. Scored hypotheses, never causal claims.
No correlated events found in the current window. As more events arrive, connections form automatically.